Beta-blockers to prevent symptomatic heart failure in patients with stage A and B heart failure

被引:4
|
作者
Wild D.M. [1 ]
Kukin M. [1 ]
机构
[1] Cardiology Clark 3, New York, NY 10025
关键词
Chronic Heart Failure; Carvedilol; Symptomatic Heart Failure; Symptomatic Stage; Metoprolol Succinate;
D O I
10.1007/s11897-007-0007-4
中图分类号
学科分类号
摘要
β-blockers have been well-studied in the treatment of the symptomatic stages of chronic heart failure. Frequently physicians treat patients with asymptomatic left ventricular (LV) dysfunction and patients with hypertension on β-blockers without clear evidence that there is value in doing so. Chronic heart failure poses an extraordinary economic burden; any effective therapy that limits the progression to symptomatic heart failure can probably reduce monetary expenditures in addition to potentially reducing morbidity and mortality. In this article, we review the available literature on using β-blockers in stage A and B heart failure to prevent progression to the symptomatic stages. The literature reveals that there is no benefit in using β-blockers to treat essential hypertension. In patients who experience LV dysfunction post-myocardial infarction, even if asymptomatic, there is improved mortality and a trend toward a reduction in progression to symptomatic heart failure. In patients with asymptomatic chronic LV dysfunction there are data that β-blockers reduce LV dimensions and improve ejection fraction. Patients with hypertension should not be given β-blockers as primary treatment. All patients with asymptomatic LV dysfunction should be treated with a β-blocker, regardless of whether they experienced myocardial infarction. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:99 / 102
页数:3
相关论文
共 50 条
  • [1] Beta-blockers in heart failure
    Yudkin, J
    [J]. DIABETIC MEDICINE, 1999, 16 (09) : 785 - 787
  • [2] Beta-blockers in heart failure
    Cohn, JN
    [J]. EUROPEAN HEART JOURNAL, 1998, 19 : F52 - F55
  • [3] Titration of beta-blockers in heart failure patients
    Luzier, A
    Antell, LA
    Chang, LL
    Xuan, JW
    Roth, DA
    [J]. CIRCULATION, 2001, 104 (17) : 717 - 718
  • [4] The beta-blockers in elderly patients with heart failure
    Daniel, Carlos
    Bevacqua, Raul J.
    [J]. INSUFICIENCIA CARDIACA, 2009, 4 (03) : 142 - 148
  • [5] Heart failure:: a role for beta-blockers
    Mahé, I
    [J]. PRESSE MEDICALE, 1999, 28 (20): : 1072 - 1072
  • [6] BETA-BLOCKERS IN HEART-FAILURE
    BROWN, MJ
    [J]. LANCET, 1994, 343 (8894): : 425 - 425
  • [7] Beta-blockers in heart failure.
    Vanhaecke, J
    Droogne, W
    VanCleemput, J
    VandeWerf, F
    [J]. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1997, 46 (08): : 527 - 529
  • [8] Therapy of heart failure with beta-blockers
    Laufs, U
    Erdmann, E
    [J]. HERZ KREISLAUF, 1999, 31 (09): : 363 - 366
  • [9] An overview of beta-blockers and heart failure
    Jafri, SM
    [J]. HEART FAILURE REVIEWS, 2004, 9 (02) : 89 - 89
  • [10] Baroreceptors and beta-blockers in heart failure
    Sanderson, JE
    Yeung, LY
    Chan, SK
    Yu, CM
    Kay, R
    Bernardi, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 84141 - 84141